The Supreme Court held that the restaurant mark NANDHINI was not deceptively similar to the dairy federation's NANDINI, because the goods, trade channels and consumers differed. A proprietor cannot monopolise an entire class of goods, only the goods it actually deals in.
On 8 June 2026 the Bombay High Court restrained Numen Pharma from using the mark 'ACIPROX', holding it phonetically similar to Alkem's registered 'ALCIPRO'. Justice Sharmila U. Deshmukh applied the heightened pharmaceutical confusion standard — the bare possibility of confusion is enough to injunct — and refused to dissect the rival marks syllable by syllable.